A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease

Abstract
Objective: To evaluate the nonergot dopamine agonist ropinirole as an adjunct to L-dopa in a randomized, double-blind trial in PD patients with motor fluctuations.